Can an Irish pharmacy dispense a prescription from an EU doctor?

The short answer, before the detail

An Irish pharmacy can dispense a prescription written by a prescriber registered in another EU or EEA country, provided the prescription contains the details required by EU law and the pharmacist is satisfied it is genuine and clinically appropriate. The Pharmaceutical Society of Ireland, the regulator for pharmacy in Ireland, publishes guidance for pharmacists on exactly this situation, which tells you it is a recognised and routine question rather than a loophole.

What the law does not do is oblige a pharmacist to dispense. Recognition means the prescription cannot be refused simply because it was written abroad. It does not remove the pharmacist's own professional judgement, and it does not override Irish rules on controlled medicines. So the honest framing is this: a cross-border prescription is normally dispensable, occasionally queried, and in a small number of categories not usable in Ireland at all.

The legal basis: two EU instruments, not Irish goodwill

Two pieces of EU law sit behind this. Directive 2011/24/EU on the application of patients' rights in cross-border healthcare establishes that a prescription issued in one member state for a medicine authorised for marketing in another can be dispensed in that other state. Implementing Directive 2012/52/EU then does the practical work: it lays down a minimum list of elements a prescription must contain if it is to be recognised across borders.

That second document is the one that matters at the pharmacy counter. Its annex is essentially a checklist. If every item on the checklist is present and legible, the pharmacist has what the law says is needed to identify the patient, identify the prescriber, and identify the medicine unambiguously. If items are missing, the pharmacist is entitled to hold the prescription until the gap is filled.

Neither directive creates a special category of prescription. There is no separate EU form and no stamp that makes a prescription cross-border. A perfectly ordinary prescription that happens to carry all the required elements is a cross-border prescription.

What the prescription must contain

The elements set out in Implementing Directive 2012/52/EU cover three groups. Patient identification: family name, first name written out in full, and date of birth. Prescription authentication: the date it was issued, and the prescriber's signature, whether handwritten or in digital form. Prescriber identification: family name and first name in full, professional qualification, direct contact details including e-mail and a telephone or fax number with the international dialling prefix, work address including the member state, and the country of registration.

The medicine itself is identified by its common name, meaning the international non-proprietary name of the active substance rather than a brand. A brand name may be used where the product is biological, or where the prescriber considers it medically necessary and gives a short statement of the reason. The document also states the pharmaceutical form, the quantity, the strength and the dosage regimen.

The reason for the emphasis on the generic name is simple. Brand names differ between member states, and the same brand can cover different strengths in different markets. The active substance does not change at a border.

What the pharmacist actually checks

Expect a working check rather than a formality. A pharmacist in Ireland will look at whether the required details are present and legible, whether the medicine named is authorised here, whether the strength and quantity make sense for the stated regimen, and whether anything about the document raises a question of authenticity. Contact details for the prescriber are on the list precisely so that a query can be raised directly.

Professional discretion sits above all of that. A pharmacist who is not satisfied that dispensing would be safe or appropriate can decline, and that applies to Irish prescriptions too. The realistic failure modes are prosaic: an illegible signature, a missing date of birth, a brand name with no generic equivalent stated, or a quantity that does not match the regimen.

Bring photo identification. A cross-border prescription identifies you by name and date of birth, so being able to show that you are the person named removes the most common friction at the counter.

Which medicines are excluded

The recognition arrangement does not extend to everything. Directive 2011/24/EU allows member states to exclude medicinal products subject to special prescription requirements, and in practice narcotic and psychotropic medicines are handled nationally rather than across borders. In Irish terms, that means anything falling under the controlled drugs schedules is outside this route.

For patients, the practical list is worth memorising: opioid painkillers, benzodiazepines, Z-drugs used for sleep, stimulants used in ADHD, and cannabis-based products. MEDINOW also does not issue gabapentinoids such as pregabalin and gabapentin. If your treatment is in any of those groups, a cross-border prescription is not the answer and you need care inside the Irish system, through a GP, an out-of-hours service or a hospital clinic depending on the situation.

Unlicensed and specials-type products are a second gap. If a medicine is not authorised for marketing in Ireland, recognition of the prescription does not create a supply route for it. The pharmacist can only dispense what can lawfully be supplied here.

Recognition is not reimbursement

A prescription being dispensable and a prescription being paid for are two different questions, and mixing them up causes most of the disappointment on this topic. Recognition under EU law says the pharmacy may dispense. It says nothing about who pays.

In Ireland, community reimbursement runs through HSE schemes such as the medical card, the GP visit card and the Drugs Payment Scheme, each with its own eligibility rules and its own rules about which prescriptions and which products qualify. Whether a prescription written outside Ireland can be processed under a given scheme is a question for the HSE and for the pharmacy, not something EU recognition settles. Check the current rules with the HSE before assuming a scheme applies.

The safe planning assumption is that you may be paying the retail price at the counter, which is worth confirming before you order anything expensive.

Paper, PDF and what arrives by e-mail

Irish e-prescribing infrastructure is domestic, so a prescription written by a doctor registered in another member state does not travel down it and reaches you as a document instead.

MEDINOW issues that document as a PDF built to the annex of Implementing Directive 2012/52/EU and sends it by e-mail. There is no PIN code, no Irish patient number and no PPS number involved, because none of those belong to this route. You bring the document to any pharmacy, along with photo identification in the name on the prescription.

We do not name a pharmacy for you, and you should be sceptical of any service that does. Pharmacies differ in stock and in how they handle a document they have not seen before. Ringing ahead to check that the item is in stock is more useful than choosing a chain.

Where MEDINOW fits, and where it does not

MEDINOW is operated by MEDINOW Sp. z o.o. Assessments are carried out by lek. Damian Wojno, a doctor registered in Poland, PWZ no. 3211301. He is not registered with the medical regulator in Ireland, and we do not claim otherwise. What EU law provides for is recognition of the prescription he writes, not a second registration.

Our model is a written medical questionnaire that the doctor reads and answers in his own time. There is no video consultation, no telephone appointment and no live chat. That is a real difference from an Irish online doctor service, and it is why our route suits continuation of treatment you are already established on rather than a new problem that needs examining.

Two assessments are available. A repeat prescription assessment at 19.90 euro, for treatment you are already taking and which is stable. A weight management assessment at 29.90 euro. The fee covers the medical assessment, not the issuing of a document. If the doctor declines on medical grounds, the fee is refunded. If the doctor asks for documentation, such as recent blood results or a copy of an earlier prescription, and it is not supplied, the assessment counts as carried out and the fee is not refunded.